The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•26 April 2026•

1 min read

Elevance Health Insiders Signal Confidence with $3.68M Share Purchase

Key Facts

1Insiders at Elevance Health purchased $3.68 million worth of shares over the last 12 months.

2President Gail Boudreaux purchased $2.1 million worth of shares at a price below the current market value.

Recent filings reveal significant insider buying activity at Elevance Health (ELV), with insiders purchasing $3.68 million worth of shares over the past 12 months. Leading the trend, CEO Gail Boudreaux acquired shares valued at $2.1 million at prices currently below the prevailing market value. This net buying activity suggests a robust internal confidence in the company's long-term prospects and underlying valuation. Analysts typically view such substantial executive investments as a bullish signal for retail and institutional investors alike. Despite some minor selling activity in the broader sector, the commitment from Elevance's top leadership stands out as a positive indicator. This move is expected to bolster investor sentiment regarding the healthcare giant's future performance.